Drugplain

Sheffield Triple Antibiotic Plus Pain Relief 500 [USP'U]/g

Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine Hydrochloride · OINTMENT · Sheffield Pharmaceuticals LLC

No Recall History
Plain English

Sheffield Triple Antibiotic Plus Pain Relief is a ointment containing bacitracin zinc, polymyxin b sulfate, neomycin sulfate, pramoxine hydrochloride at 500 [USP'U]/g, taken topical. Manufactured by Sheffield Pharmaceuticals LLC.

Key Facts

Brand Name
Sheffield Triple Antibiotic Plus Pain Relief
Generic Name
Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine Hydrochloride
NDC Code (Product)
11527-161
Manufacturer
Sheffield Pharmaceuticals LLC
Strength
500 [USP'U]/g
Dosage Form
OINTMENT
Route
TOPICAL
Marketing Status
Application #
M004
Marketing Start
01/23/2011

Recall History

No Recall History

Frequently Asked Questions

What is Sheffield Triple Antibiotic Plus Pain Relief used for?

Sheffield Triple Antibiotic Plus Pain Relief contains Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine Hydrochloride. It is a ointment taken topical. Consult your doctor for specific uses.

Is Sheffield Triple Antibiotic Plus Pain Relief a controlled substance?

Sheffield Triple Antibiotic Plus Pain Relief is not classified as a controlled substance by the DEA.

What is the generic name for Sheffield Triple Antibiotic Plus Pain Relief?

The generic name for Sheffield Triple Antibiotic Plus Pain Relief is Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine Hydrochloride. There are no other listed brand versions of Bacitracin Zinc, Polymyxin B Sulfate, Neomycin Sulfate, Pramoxine Hydrochloride.

What is the NDC code for Sheffield Triple Antibiotic Plus Pain Relief 500 [USP'U]/g?

The NDC (National Drug Code) for Sheffield Triple Antibiotic Plus Pain Relief 500 [USP'U]/g is 11527-161, listed by Sheffield Pharmaceuticals LLC.

Product NDC

11527-161

Package NDC

11527-161-55

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)